 | • レポートコード：MRC773KR3392 • 出版社/出版日：GlobalInfoResearch / 2026年2月 • レポート形態：英語、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥539,400 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥809,100 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,078,800 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当社（Global Info Research）の最新調査によると、世界の不妊治療市場規模は2025年に60億5800万米ドルと評価され、調査期間中の年平均成長率（CAGR）6.1％で推移し、2032年までに91億100万米ドルに達すると予測されています。 不妊治療薬とは、生殖能力を高める薬剤のことです。女性の場合、不妊治療薬は卵巣の卵胞発育を刺激するために使用されます。卵巣の活動を促進する薬剤は、ゴナドトロピン放出ホルモン、エストロゲン拮抗薬、またはゴナドトロピンのいずれかに分類されます。 世界の不妊治療薬市場の主要企業には、メルク、フェリング、MSD、LIVZON、アボットなどが挙げられます。世界のトップ5メーカーが約60％のシェアを占めています。 北米が30％超のシェアを占める最大の市場であり、次いで中国、欧州がそれぞれ約40％のシェアを占めています。 製品別では、女性用不妊治療薬が85％超のシェアを占め、最大のセグメントとなっています。また、用途別では、ドラッグストアが最大の用途であり、次いで病院、オンラインなどが続きます。 本レポートは、世界の不妊治療市場に関する詳細かつ包括的な分析です。企業別、地域・国別、タイプ別、用途別に、定量的および定性的な分析が提示されています。市場は絶えず変化しているため、本レポートでは、競争状況、需給動向、および多くの市場における需要変化に寄与する主要因について探求しています。選定された競合他社の企業概要や製品事例に加え、2025年時点における主要企業の市場シェア推計値も提供されています。 主な特徴： 世界の不妊治療市場規模および予測（消費額、単位：百万ドル）、2021年～2032年 地域および国別の世界不妊治療市場規模および予測（消費額、単位：百万ドル）、2021年～2032年 種類および用途別の世界不妊治療市場規模および予測（消費額、単位：百万ドル）、2021年～2032年 主要企業の世界不妊治療市場シェア（売上高、単位：百万ドル）、2021年～2026年 本レポートの主な目的は以下の通りです： 世界および主要国における総市場機会の規模を特定すること 不妊治療の成長ポテンシャルを評価すること 各製品およびエンドユース市場における将来の成長を予測すること 市場に影響を与える競争要因を評価すること 本レポートでは、以下のパラメータ（会社概要、売上高、粗利益率、製品ポートフォリオ、地理的展開、および主な動向）に基づき、世界の不妊治療市場の主要企業を分析しています。本調査で取り上げている主要企業には、メルク、フェリング、MSD、LIVZON、アボット、バイエル、ザイダス・ファーマ、チャーチ＆ドワイト、SASMAR、BioFilm,Inc、FAIRHAVEN HEALTHなどが含まれます。 本レポートでは、市場の推進要因、制約要因、機会、新製品の発売や承認に関する重要な洞察も提供しています。 市場セグメンテーション 不妊治療薬市場は、タイプ別および用途別に分類されています。2021年から2032年までの期間において、各セグメントの成長動向に基づき、タイプ別および用途別の消費額に関する正確な算出と予測が提示されています。この分析は、有望なニッチ市場をターゲットにすることで、ビジネスの拡大に役立てることができます。 タイプ別市場セグメント 女性用不妊治療薬 男性用不妊治療薬 OTC（一般用医薬品）受胎用ジェル／潤滑剤 用途別市場セグメント 病院 ドラッグストア オンライン 企業別市場セグメント：本レポートでは以下の企業を網羅しています メルク フェリング MSD LIVZON アボット バイエル・ザイダス・ファーマ チャーチ＆ドワイト SASMAR BioFilm,Inc FAIRHAVEN HEALTH The YES YES Company 地域別市場セグメント、地域分析の対象 北米（米国、カナダ、メキシコ） 欧州（ドイツ、フランス、英国、ロシア、イタリア、その他の欧州諸国） アジア太平洋（中国、日本、韓国、インド、東南アジア、その他のアジア太平洋諸国） 南米（ブラジル、その他の南米諸国） 中東・アフリカ（トルコ、サウジアラビア、UAE、その他の中東・アフリカ諸国） |
According to our (Global Info Research) latest study, the global Fertility Enhancing Treatment market size was valued at US$ 6058 million in 2025 and is forecast to a readjusted size of US$ 9101 million by 2032 with a CAGR of 6.1% during review period.
Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
Global Fertility Enhancing Treatment key players include Merck, Ferring, MSD, LIVZON, Abbott, etc. Global top five manufacturers hold a share about 60%.
North America is the largest market, with a share over 30%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Fertility Drugs for Women is the largest segment, with a share over 85%. And in terms of application, the largest application is Drug Stores, followed by Hospitals, Online, etc.
This report is a detailed and comprehensive analysis for global Fertility Enhancing Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fertility Enhancing Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Fertility Enhancing Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Fertility Enhancing Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Fertility Enhancing Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fertility Enhancing Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fertility Enhancing Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church＆Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Fertility Enhancing Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fertility Drugs for Women
Fertility Drugs for Men
OTC Conception Gels/Lubricants
Market segment by Application
Hospitals
Drug Stores
Online
Market segment by players, this report covers
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church＆Dwight
SASMAR
BioFilm,Inc
FAIRHAVEN HEALTH
The YES YES Company
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Fertility Enhancing Treatment by Type
1.3.1 Overview: Global Fertility Enhancing Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Fertility Enhancing Treatment Consumption Value Market Share by Type in 2025
1.3.3 Fertility Drugs for Women
1.3.4 Fertility Drugs for Men
1.3.5 OTC Conception Gels/Lubricants
1.4 Global Fertility Enhancing Treatment Market by Application
1.4.1 Overview: Global Fertility Enhancing Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals
1.4.3 Drug Stores
1.4.4 Online
1.5 Global Fertility Enhancing Treatment Market Size & Forecast
1.6 Global Fertility Enhancing Treatment Market Size and Forecast by Region
1.6.1 Global Fertility Enhancing Treatment Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Fertility Enhancing Treatment Market Size by Region, (2021-2032)
1.6.3 North America Fertility Enhancing Treatment Market Size and Prospect (2021-2032)
1.6.4 Europe Fertility Enhancing Treatment Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Fertility Enhancing Treatment Market Size and Prospect (2021-2032)
1.6.6 South America Fertility Enhancing Treatment Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Fertility Enhancing Treatment Market Size and Prospect (2021-2032)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Fertility Enhancing Treatment Product and Solutions
2.1.4 Merck Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck Recent Developments and Future Plans
2.2 Ferring
2.2.1 Ferring Details
2.2.2 Ferring Major Business
2.2.3 Ferring Fertility Enhancing Treatment Product and Solutions
2.2.4 Ferring Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ferring Recent Developments and Future Plans
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Fertility Enhancing Treatment Product and Solutions
2.3.4 MSD Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 MSD Recent Developments and Future Plans
2.4 LIVZON
2.4.1 LIVZON Details
2.4.2 LIVZON Major Business
2.4.3 LIVZON Fertility Enhancing Treatment Product and Solutions
2.4.4 LIVZON Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 LIVZON Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Fertility Enhancing Treatment Product and Solutions
2.5.4 Abbott Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Bayer Zydus Pharma
2.6.1 Bayer Zydus Pharma Details
2.6.2 Bayer Zydus Pharma Major Business
2.6.3 Bayer Zydus Pharma Fertility Enhancing Treatment Product and Solutions
2.6.4 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bayer Zydus Pharma Recent Developments and Future Plans
2.7 Church＆Dwight
2.7.1 Church＆Dwight Details
2.7.2 Church＆Dwight Major Business
2.7.3 Church＆Dwight Fertility Enhancing Treatment Product and Solutions
2.7.4 Church＆Dwight Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Church＆Dwight Recent Developments and Future Plans
2.8 SASMAR
2.8.1 SASMAR Details
2.8.2 SASMAR Major Business
2.8.3 SASMAR Fertility Enhancing Treatment Product and Solutions
2.8.4 SASMAR Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SASMAR Recent Developments and Future Plans
2.9 BioFilm,Inc
2.9.1 BioFilm,Inc Details
2.9.2 BioFilm,Inc Major Business
2.9.3 BioFilm,Inc Fertility Enhancing Treatment Product and Solutions
2.9.4 BioFilm,Inc Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BioFilm,Inc Recent Developments and Future Plans
2.10 FAIRHAVEN HEALTH
2.10.1 FAIRHAVEN HEALTH Details
2.10.2 FAIRHAVEN HEALTH Major Business
2.10.3 FAIRHAVEN HEALTH Fertility Enhancing Treatment Product and Solutions
2.10.4 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 FAIRHAVEN HEALTH Recent Developments and Future Plans
2.11 The YES YES Company
2.11.1 The YES YES Company Details
2.11.2 The YES YES Company Major Business
2.11.3 The YES YES Company Fertility Enhancing Treatment Product and Solutions
2.11.4 The YES YES Company Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 The YES YES Company Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fertility Enhancing Treatment Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Fertility Enhancing Treatment by Company Revenue
3.2.2 Top 3 Fertility Enhancing Treatment Players Market Share in 2025
3.2.3 Top 6 Fertility Enhancing Treatment Players Market Share in 2025
3.3 Fertility Enhancing Treatment Market: Overall Company Footprint Analysis
3.3.1 Fertility Enhancing Treatment Market: Region Footprint
3.3.2 Fertility Enhancing Treatment Market: Company Product Type Footprint
3.3.3 Fertility Enhancing Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Fertility Enhancing Treatment Consumption Value and Market Share by Type (2021-2026)
4.2 Global Fertility Enhancing Treatment Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
5.1 Global Fertility Enhancing Treatment Consumption Value Market Share by Application (2021-2026)
5.2 Global Fertility Enhancing Treatment Market Forecast by Application (2027-2032)
6 North America
6.1 North America Fertility Enhancing Treatment Consumption Value by Type (2021-2032)
6.2 North America Fertility Enhancing Treatment Market Size by Application (2021-2032)
6.3 North America Fertility Enhancing Treatment Market Size by Country
6.3.1 North America Fertility Enhancing Treatment Consumption Value by Country (2021-2032)
6.3.2 United States Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
6.3.3 Canada Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
6.3.4 Mexico Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
7 Europe
7.1 Europe Fertility Enhancing Treatment Consumption Value by Type (2021-2032)
7.2 Europe Fertility Enhancing Treatment Consumption Value by Application (2021-2032)
7.3 Europe Fertility Enhancing Treatment Market Size by Country
7.3.1 Europe Fertility Enhancing Treatment Consumption Value by Country (2021-2032)
7.3.2 Germany Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
7.3.3 France Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
7.3.5 Russia Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
7.3.6 Italy Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8 Asia-Pacific
8.1 Asia-Pacific Fertility Enhancing Treatment Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Fertility Enhancing Treatment Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Fertility Enhancing Treatment Market Size by Region
8.3.1 Asia-Pacific Fertility Enhancing Treatment Consumption Value by Region (2021-2032)
8.3.2 China Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8.3.3 Japan Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8.3.4 South Korea Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8.3.5 India Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
8.3.7 Australia Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
9 South America
9.1 South America Fertility Enhancing Treatment Consumption Value by Type (2021-2032)
9.2 South America Fertility Enhancing Treatment Consumption Value by Application (2021-2032)
9.3 South America Fertility Enhancing Treatment Market Size by Country
9.3.1 South America Fertility Enhancing Treatment Consumption Value by Country (2021-2032)
9.3.2 Brazil Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
9.3.3 Argentina Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
10 Middle East & Africa
10.1 Middle East & Africa Fertility Enhancing Treatment Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Fertility Enhancing Treatment Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Fertility Enhancing Treatment Market Size by Country
10.3.1 Middle East & Africa Fertility Enhancing Treatment Consumption Value by Country (2021-2032)
10.3.2 Turkey Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
10.3.4 UAE Fertility Enhancing Treatment Market Size and Forecast (2021-2032)
11 Market Dynamics
11.1 Fertility Enhancing Treatment Market Drivers
11.2 Fertility Enhancing Treatment Market Restraints
11.3 Fertility Enhancing Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Fertility Enhancing Treatment Industry Chain
12.2 Fertility Enhancing Treatment Upstream Analysis
12.3 Fertility Enhancing Treatment Midstream Analysis
12.4 Fertility Enhancing Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Fertility Enhancing Treatment Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Fertility Enhancing Treatment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Fertility Enhancing Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Fertility Enhancing Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Merck Company Information, Head Office, and Major Competitors
Table 6. Merck Major Business
Table 7. Merck Fertility Enhancing Treatment Product and Solutions
Table 8. Merck Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Merck Recent Developments and Future Plans
Table 10. Ferring Company Information, Head Office, and Major Competitors
Table 11. Ferring Major Business
Table 12. Ferring Fertility Enhancing Treatment Product and Solutions
Table 13. Ferring Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Ferring Recent Developments and Future Plans
Table 15. MSD Company Information, Head Office, and Major Competitors
Table 16. MSD Major Business
Table 17. MSD Fertility Enhancing Treatment Product and Solutions
Table 18. MSD Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. LIVZON Company Information, Head Office, and Major Competitors
Table 20. LIVZON Major Business
Table 21. LIVZON Fertility Enhancing Treatment Product and Solutions
Table 22. LIVZON Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. LIVZON Recent Developments and Future Plans
Table 24. Abbott Company Information, Head Office, and Major Competitors
Table 25. Abbott Major Business
Table 26. Abbott Fertility Enhancing Treatment Product and Solutions
Table 27. Abbott Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Abbott Recent Developments and Future Plans
Table 29. Bayer Zydus Pharma Company Information, Head Office, and Major Competitors
Table 30. Bayer Zydus Pharma Major Business
Table 31. Bayer Zydus Pharma Fertility Enhancing Treatment Product and Solutions
Table 32. Bayer Zydus Pharma Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Bayer Zydus Pharma Recent Developments and Future Plans
Table 34. Church＆Dwight Company Information, Head Office, and Major Competitors
Table 35. Church＆Dwight Major Business
Table 36. Church＆Dwight Fertility Enhancing Treatment Product and Solutions
Table 37. Church＆Dwight Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Church＆Dwight Recent Developments and Future Plans
Table 39. SASMAR Company Information, Head Office, and Major Competitors
Table 40. SASMAR Major Business
Table 41. SASMAR Fertility Enhancing Treatment Product and Solutions
Table 42. SASMAR Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. SASMAR Recent Developments and Future Plans
Table 44. BioFilm,Inc Company Information, Head Office, and Major Competitors
Table 45. BioFilm,Inc Major Business
Table 46. BioFilm,Inc Fertility Enhancing Treatment Product and Solutions
Table 47. BioFilm,Inc Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. BioFilm,Inc Recent Developments and Future Plans
Table 49. FAIRHAVEN HEALTH Company Information, Head Office, and Major Competitors
Table 50. FAIRHAVEN HEALTH Major Business
Table 51. FAIRHAVEN HEALTH Fertility Enhancing Treatment Product and Solutions
Table 52. FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. FAIRHAVEN HEALTH Recent Developments and Future Plans
Table 54. The YES YES Company Company Information, Head Office, and Major Competitors
Table 55. The YES YES Company Major Business
Table 56. The YES YES Company Fertility Enhancing Treatment Product and Solutions
Table 57. The YES YES Company Fertility Enhancing Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. The YES YES Company Recent Developments and Future Plans
Table 59. Global Fertility Enhancing Treatment Revenue (USD Million) by Players (2021-2026)
Table 60. Global Fertility Enhancing Treatment Revenue Share by Players (2021-2026)
Table 61. Breakdown of Fertility Enhancing Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Fertility Enhancing Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 63. Head Office of Key Fertility Enhancing Treatment Players
Table 64. Fertility Enhancing Treatment Market: Company Product Type Footprint
Table 65. Fertility Enhancing Treatment Market: Company Product Application Footprint
Table 66. Fertility Enhancing Treatment New Market Entrants and Barriers to Market Entry
Table 67. Fertility Enhancing Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Fertility Enhancing Treatment Consumption Value (USD Million) by Type (2021-2026)
Table 69. Global Fertility Enhancing Treatment Consumption Value Share by Type (2021-2026)
Table 70. Global Fertility Enhancing Treatment Consumption Value Forecast by Type (2027-2032)
Table 71. Global Fertility Enhancing Treatment Consumption Value by Application (2021-2026)
Table 72. Global Fertility Enhancing Treatment Consumption Value Forecast by Application (2027-2032)
Table 73. North America Fertility Enhancing Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 74. North America Fertility Enhancing Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 75. North America Fertility Enhancing Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 76. North America Fertility Enhancing Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 77. North America Fertility Enhancing Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America Fertility Enhancing Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe Fertility Enhancing Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 80. Europe Fertility Enhancing Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 81. Europe Fertility Enhancing Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 82. Europe Fertility Enhancing Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 83. Europe Fertility Enhancing Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 84. Europe Fertility Enhancing Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 85. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 86. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 87. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 88. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 89. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Fertility Enhancing Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 91. South America Fertility Enhancing Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 92. South America Fertility Enhancing Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 93. South America Fertility Enhancing Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 94. South America Fertility Enhancing Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 95. South America Fertility Enhancing Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 96. South America Fertility Enhancing Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 98. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 99. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Fertility Enhancing Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Global Key Players of Fertility Enhancing Treatment Upstream (Raw Materials)
Table 104. Global Fertility Enhancing Treatment Typical Customers
自律神経失調症の市場規模、疫学、治療薬販売、パイプライン、地域別展望2025-2035 The dysautonomia market reached a value of USD 2.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 6.2 Billion by 2035, exhibiting a growth rate (CAGR) of 9.39% during 2025-2035. The dysautonomia market has …- 世界のVHH抗体医薬品市場 2025年 According to our (Global Info Research) latest study, the global VHH Antibody Drugs market size was valued at US$ xx million in 2024 and is forecast to a readjusted size of USD xx million by 2031 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global…
- タクシーの世界市場2026 According to our (Global Info Research) latest study, the global Taxi market size was valued at US$ xx million in 2025 and is forecast to a readjusted size of USD xx million by 2032 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global Taxi market. …
- 透明ディスプレイの世界市場2026 According to our (Global Info Research) latest study, the global Transparent Display market size was valued at US$ 455 million in 2025 and is forecast to a readjusted size of US$ 765 million by 2032 with a CAGR of 7.8% during review period. Transparent displays have many possible applications, such …
- ARおよびVRディスプレイの世界市場2026 According to our (Global Info Research) latest study, the global AR and VR Display market size was valued at US$ xx million in 2025 and is forecast to a readjusted size of USD xx million by 2032 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global …